Sino Biological,Inc. (SHE:301047)
73.10
-0.73 (-0.99%)
At close: May 12, 2026
Sino Biological,Inc. Market Cap
Sino Biological,Inc. has a market cap or net worth of 8.98 billion as of May 12, 2026. Its market cap has increased by 20.83% in one year.
Market Cap
8.98B
Enterprise Value
5.77B
Revenue
727.69M
Ranking
n/a
PE Ratio
57.11
Stock Price
73.10
Market Cap Chart
Since August 16, 2021, Sino Biological,Inc.'s market cap has decreased from 33.55B to 8.98B, a decrease of -73.23%. That is a compound annual growth rate of -24.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 8.98B | 9.22% |
| Dec 31, 2025 | 8.22B | 9.30% |
| Dec 31, 2024 | 7.52B | -29.33% |
| Dec 29, 2023 | 10.65B | -17.32% |
| Dec 30, 2022 | 12.88B | -45.23% |
| Dec 31, 2021 | 23.51B | -29.92% |
| Aug 16, 2021 | 33.55B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangxi Fushine Pharmaceutical | 9.90B |
| Liaoning Chengda Biotechnology | 9.78B |
| Youcare Pharmaceutical Group | 9.56B |
| Daan Gene | 9.32B |
| Aurisco Pharmaceutical | 9.23B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 8.94B |
| GemPharmatech | 8.40B |
| Zhejiang Ausun Pharmaceutical | 8.38B |